With billions of doses of Covid-19 expected to be available by year’s end, and a global population of 7.8 billion, public health officials are scrambling to deliver the vaccines in ways that are equitable and effective. The challenge is about more than having a vaccine, and more than delivering it, public health experts at Johns Hopkins Medical School explained during a media briefing.
A new $1 billion fund backed by 20 drugmakers including Merck & Co. Inc. and Pfizer Inc. is aiming to bolster struggling antibiotic companies and sustain a pipeline for new treatments.
The United States surpassed Italy on Saturday as the country with the highest reported coronavirus death toll, recording more than 20,000 deaths since the outbreak began, according to a Reuters tally.
Join Ipsos for an interactive, complimentary “Ask us anything” webinar examining how public mood is changing as a result of Covid-19, where concerns are most focused now, and how the crisis is affecting American’s behavior now and in the future.
The U.S. Food and Drug Administration is putting a halt to the sale of alleged treatments for COVID-19 due to concerns about the safety risks these products could have to the public.
AstraZeneca announced a bold plan to have zero carbon emissions from the company’s global operations within the next five years.
Researchers say universities across the United States have been slow to adopt anti-tobacco policies on campuses despite public health efforts to curb tobacco use, especially among teens and young adults.
Scientists have found multidrug-resistant “superbug” bacteria lurking on cash machines, escalators and handrails in London’s underground rail system, shopping centers and hospitals and say they pose a potential risk to public health.